|
MRPL9 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.58089999979794E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.49519999998105E-06 |
| Normal-vs-Stage2 |
5.621100E-03 |
| Normal-vs-Stage3 |
1.838200E-02 |
| Normal-vs-Stage4 |
2.08969999999642E-05 |
| Stage1-vs-Stage2 |
6.195800E-01 |
| Stage1-vs-Stage3 |
4.479400E-01 |
| Stage1-vs-Stage4 |
1.287180E-01 |
| Stage2-vs-Stage3 |
3.812200E-01 |
| Stage2-vs-Stage4 |
5.361000E-01 |
| Stage3-vs-Stage4 |
8.382500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.28519999987154E-07 |
| Normal-vs-AfricanAmerican |
1.957060E-03 |
| Normal-vs-Asian |
1.299840E-01 |
| Caucasian-vs-AfricanAmerican |
6.303000E-01 |
| Caucasian-vs-Asian |
7.164800E-01 |
| AfricanAmerican-vs-Asian |
8.589000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.88700000000242E-05 |
| Normal-vs-Female |
1.00950000025968E-07 |
| Male-vs-Female |
1.557980E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.304000E-02 |
| Normal-vs-Age(41-60Yrs) |
5.59369999999504E-05 |
| Normal-vs-Age(61-80Yrs) |
2.35209999999153E-06 |
| Normal-vs-Age(81-100Yrs) |
6.149800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.232400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.516000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.215800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.872000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.421000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.069000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.2375000003082E-07 |
| Normal-vs-Grade 2 |
1.49560000051174E-07 |
| Normal-vs-Grade 3 |
3.782100E-04 |
| Normal-vs-Grade 4 |
6.439900E-03 |
| Grade 1-vs-Grade 2 |
3.039700E-02 |
| Grade 1-vs-Grade 3 |
1.161680E-02 |
| Grade 1-vs-Grade 4 |
2.608200E-02 |
| Grade 2-vs-Grade 3 |
4.006600E-01 |
| Grade 2-vs-Grade 4 |
5.610200E-01 |
| Grade 3-vs-Grade 4 |
9.373400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.6517998907849E-10 |
| Normal-vs-ccB subtype |
2.129400E-01 |
| ccA subtype-vs-ccB subtype |
4.802200E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.37860000000301E-05 |
| Normal-vs-N1 |
5.530100E-02 |
| N0-vs-N1 |
2.638000E-01 |
|
|
